CLVS Insider Trading Activity and SEC Form 4 Filings
CLVS insider trading summary
No open-market insider purchases or sales of Clovis Oncology, Inc. (CLVS) have been reported on SEC Form 4 in the past 12 months.
Latest CLVS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 2, 2022 | Thomas C. Harding | See Remarks | Sell | $62 (63 @ $0.98) |
| Nov 2, 2022 | Paul Edward Gross | See Remarks | Sell | $3K (2,595 @ $0.98) |
| Nov 2, 2022 | Paul Edward Gross | See Remarks | Sell | $2K (2,135 @ $0.98) |
| Nov 2, 2022 | Daniel W Muehl | See Remarks | Sell | $2K (2,066 @ $0.98) |
| Nov 2, 2022 | Thomas C. Harding | See Remarks | Sell | $775 (788 @ $0.98) |
| Nov 2, 2022 | Lindsey Rolfe | See Remarks | Sell | $2K (1,908 @ $0.98) |
| Nov 2, 2022 | Daniel W Muehl | See Remarks | Sell | $2K (2,513 @ $0.98) |
| Nov 2, 2022 | Gillian C Ivers-Read | See Remarks | Sell | $2K (2,006 @ $0.98) |
| Nov 2, 2022 | Gillian C Ivers-Read | See Remarks | Sell | $2K (1,675 @ $0.98) |
| Nov 2, 2022 | Lindsey Rolfe | See Remarks | Sell | $2K (2,353 @ $0.98) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.